BioEclipse Therapeutics, Inc. — Form C (Regulation Crowdfunding)
BioEclipse Therapeutics, Inc. of Mountain View, CA filed a Form C (Regulation Crowdfunding) with the SEC on 2022-01-19. Target raise $10K, up to $1.1M. Offered through NetCapital Funding Portal Inc..
Offering
- Filed: 2022-01-19
- Form: C
- Accession: 0001669191-22-000053
- Target amount: $10K
- Maximum amount: $1.1M
- Security type: Common Stock
- Securities offered: 3,922
- Price: $2.5500
- Deadline: 2022-03-01
- Funding portal / intermediary: NetCapital Funding Portal Inc.
- Intermediary file number: 007-00035
- Intermediary CRD: 283596
Issuer
- CIK: 0001780708
- Website: https://www.bioeclipse.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2006-05-26
- Address: 319 North Bernardo Avenue, Mountain View, CA, 94043
- Employees: 5
Financials (as filed)
- Total assets (most recent): $3.0M
- Cash (most recent): $2.3M
- Net income (most recent): $-4.4M
- Net income (prior): $-2.4M
- Short-term debt: $76K
People (7)
| Name | Role | Location |
|---|
| Mark Frohlich | Board Member | Houston, TX |
| Gregory Schiffman | Board Member | Vancouver, WA |
| Pamela Contag | Board Member | South San Francisco, CA |
| Pamela Contag | Principal Accounting Officer | South San Francisco, CA |
| Pamela Contag | Principal Executive Officer | South San Francisco, CA |
| Pamela Contag | Principal Financial Officer | South San Francisco, CA |
| Cathy Sohn | Board Member | Fort Collins, CO |
Reg CF filing history (3)
More